Literature DB >> 21346515

Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically.

Winnie C Pao1, Dennis W Dickson, Julia E Crook, NiCole A Finch, Rosa Rademakers, Neill R Graff-Radford.   

Abstract

BACKGROUND: Hippocampal sclerosis (HpScl) in the elderly is often associated with neurodegeneration.
METHODS: We studied the clinical and pathologic features of HpScl in 205 consecutive patients with dementia who came to autopsy from 1997 to 2008, focusing on associations with TAR DNA-binding protein 43 (TDP-43) pathology and allelic variants in the progranulin (GRN) and apolipoprotein E (APOE).
RESULTS: Of the 205 dementia patients, 28 had HpScl (14%). TDP-43 pathology was more frequent in cases with HpScl compared with those without HpScl (89% vs. 24%). GRN rs5848 T-allele but not APOE ε4 was associated with HpScl. In cases of HpScl with TDP-43 pathology and age of onset after 75 years (n=11), 8 had Alzheimer disease (AD)-like amnestic syndrome, but most (6 of 8) had pathology not consistent with AD (Braak stage III or less), including 4 with frontotemporal lobar degeneration with TDP, 1 with diffuse Lewy body disease, and 1 with "pure HpScl."
CONCLUSIONS: HpScl is common in an elderly cohort with dementia, occurring in 14% of the cases in this series, and 89% have TDP-43 pathology, often associated with a risk variant in GRN. Patients with HpScl who present after the age of 75 years often have presentations consistent with AD, but at autopsy have non-Alzheimer pathologies. Elderly patients with HpScl may be mistaken for AD.

Entities:  

Mesh:

Year:  2011        PMID: 21346515      PMCID: PMC3107353          DOI: 10.1097/WAD.0b013e31820f8f50

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  28 in total

1.  Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank.

Authors:  Warren W Barker; Cheryl A Luis; Alice Kashuba; Mercy Luis; Dylan G Harwood; David Loewenstein; Carol Waters; Pat Jimison; Eugene Shepherd; Steven Sevush; Neil Graff-Radford; Douglas Newland; Murray Todd; Bayard Miller; Michael Gold; Kenneth Heilman; Leilani Doty; Ira Goodman; Bruce Robinson; Gary Pearl; Dennis Dickson; Ranjan Duara
Journal:  Alzheimer Dis Assoc Disord       Date:  2002 Oct-Dec       Impact factor: 2.703

2.  Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

Authors:  B T Hyman; J Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  1997-10       Impact factor: 3.685

3.  Staging of Alzheimer-related cortical destruction.

Authors:  H Braak; E Braak
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

4.  Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.

Authors:  Dennis W Dickson; Matthew Baker; Rosa Rademakers
Journal:  Neurodegener Dis       Date:  2010-03-03       Impact factor: 2.977

5.  Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's disease.

Authors:  T A Ala; G O Beh; W H Frey
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

6.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

7.  FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.

Authors:  Hazel Urwin; Keith A Josephs; Jonathan D Rohrer; Ian R Mackenzie; Manuela Neumann; Astrid Authier; Harro Seelaar; John C Van Swieten; Jeremy M Brown; Peter Johannsen; Jorgen E Nielsen; Ida E Holm; Dennis W Dickson; Rosa Rademakers; Neill R Graff-Radford; Joseph E Parisi; Ronald C Petersen; Kimmo J Hatanpaa; Charles L White; Myron F Weiner; Felix Geser; Vivianna M Van Deerlin; John Q Trojanowski; Bruce L Miller; William W Seeley; Julie van der Zee; Samir Kumar-Singh; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Eileen H Bigio; Han-Xiang Deng; Glenda M Halliday; Jillian J Kril; David G Munoz; David M Mann; Stuart M Pickering-Brown; Valerie Doodeman; Gary Adamson; Shabnam Ghazi-Noori; Elizabeth M C Fisher; Janice L Holton; Tamas Revesz; Martin N Rossor; John Collinge; Simon Mead; Adrian M Isaacs
Journal:  Acta Neuropathol       Date:  2010-05-20       Impact factor: 17.088

8.  Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans.

Authors:  D W Dickson; P Davies; C Bevona; K H Van Hoeven; S M Factor; E Grober; M K Aronson; H A Crystal
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Variation at GRN 3'-UTR rs5848 is not associated with a risk of frontotemporal lobar degeneration in Dutch population.

Authors:  Javier Simón-Sánchez; Harro Seelaar; Zoltán Bochdanovits; Dorly J H Deeg; John C van Swieten; Peter Heutink
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

10.  No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration.

Authors:  Sara Rollinson; Jonathan D Rohrer; Julie van der Zee; Kristel Sleegers; Simon Mead; Sebastiaan Engelborghs; John Collinge; Peter P De Deyn; David M A Mann; Christine Van Broeckhoven; Stuart M Pickering-Brown
Journal:  Neurobiol Aging       Date:  2009-05-14       Impact factor: 4.673

View more
  49 in total

1.  Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.

Authors:  Naoya Aoki; Melissa E Murray; Kotaro Ogaki; Shinsuke Fujioka; Nicola J Rutherford; Rosa Rademakers; Owen A Ross; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2014-11-04       Impact factor: 17.088

Review 2.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 3.  ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.

Authors:  Peter T Nelson; Gregory A Jicha; Wang-Xia Wang; Eseosa Ighodaro; Sergey Artiushin; Colin G Nichols; David W Fardo
Journal:  Ageing Res Rev       Date:  2015-07-28       Impact factor: 10.895

4.  TDP-43 is a key player in the clinical features associated with Alzheimer's disease.

Authors:  Keith A Josephs; Jennifer L Whitwell; Stephen D Weigand; Melissa E Murray; Nirubol Tosakulwong; Amanda M Liesinger; Leonard Petrucelli; Matthew L Senjem; David S Knopman; Bradley F Boeve; Robert J Ivnik; Glenn E Smith; Clifford R Jack; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2014-03-23       Impact factor: 17.088

Review 5.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

6.  Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With Sclerosis.

Authors:  Matthew D Cykowski; Suzanne Z Powell; Paul E Schulz; Hidehiro Takei; Andreana L Rivera; Robert E Jackson; Gustavo Roman; Gregory A Jicha; Peter T Nelson
Journal:  Arch Pathol Lab Med       Date:  2017-05-03       Impact factor: 5.534

7.  Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging.

Authors:  Peter T Nelson; Yuriko Katsumata; Kwangsik Nho; Sergey C Artiushin; Gregory A Jicha; Wang-Xia Wang; Erin L Abner; Andrew J Saykin; Walter A Kukull; David W Fardo
Journal:  Acta Neuropathol       Date:  2016-11-04       Impact factor: 17.088

8.  CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRN.

Authors:  David W Fardo; Yuriko Katsumata; John S K Kauwe; Yuetiva Deming; Oscar Harari; Carlos Cruchaga; Peter T Nelson
Journal:  Exp Gerontol       Date:  2017-02-09       Impact factor: 4.032

9.  Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields.

Authors:  Kimmo J Hatanpaa; Jack M Raisanen; Emily Herndon; Dennis K Burns; Chan Foong; Amyn A Habib; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2014-02       Impact factor: 3.685

10.  Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons.

Authors:  Matthew D Cykowski; Hidehiro Takei; Linda J Van Eldik; Frederick A Schmitt; Gregory A Jicha; Suzanne Z Powell; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2016-03-12       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.